201 related articles for article (PubMed ID: 27771929)
1. The Role of Indirubins in Inflammation and Associated Tumorigenesis.
Cheng X; Merz KH
Adv Exp Med Biol; 2016; 929():269-290. PubMed ID: 27771929
[TBL] [Abstract][Full Text] [Related]
2. Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship.
Wang H; Wang Z; Wei C; Wang J; Xu Y; Bai G; Yao Q; Zhang L; Chen Y
Eur J Med Chem; 2021 Nov; 223():113652. PubMed ID: 34161865
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity of novel indirubin-5-carboxamides.
Cheng X; Rasqué P; Vatter S; Merz KH; Eisenbrand G
Bioorg Med Chem; 2010 Jun; 18(12):4509-15. PubMed ID: 20488718
[TBL] [Abstract][Full Text] [Related]
4. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins.
Knockaert M; Blondel M; Bach S; Leost M; Elbi C; Hager GL; Nagy SR; Han D; Denison M; Ffrench M; Ryan XP; Magiatis P; Polychronopoulos P; Greengard P; Skaltsounis L; Meijer L
Oncogene; 2004 May; 23(25):4400-12. PubMed ID: 15077192
[TBL] [Abstract][Full Text] [Related]
5. Indirubin derivatives: a patent review (2010 - present).
Gaboriaud-Kolar N; Vougogiannopoulou K; Skaltsounis AL
Expert Opin Ther Pat; 2015 May; 25(5):583-93. PubMed ID: 25887337
[TBL] [Abstract][Full Text] [Related]
6. CDDO and Its Role in Chronic Diseases.
Mathis BJ; Cui T
Adv Exp Med Biol; 2016; 929():291-314. PubMed ID: 27771930
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.
Cheng X; Merz KH; Vatter S; Zeller J; Muehlbeyer S; Thommet A; Christ J; Wölfl S; Eisenbrand G
J Med Chem; 2017 Jun; 60(12):4949-4962. PubMed ID: 28557430
[TBL] [Abstract][Full Text] [Related]
8. New perspective on the dual functions of indirubins in cancer therapy and neuroprotection.
Wang Y; Hoi PM; Chan JY; Lee SM
Anticancer Agents Med Chem; 2014; 14(9):1213-9. PubMed ID: 25175685
[TBL] [Abstract][Full Text] [Related]
9. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
[TBL] [Abstract][Full Text] [Related]
10. Curcumin targets in inflammation and cancer.
Deguchi A
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):88-96. PubMed ID: 25772169
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of indirubin and its derivatives.
Yang L; Li X; Huang W; Rao X; Lai Y
Biomed Pharmacother; 2022 Jul; 151():113112. PubMed ID: 35598366
[TBL] [Abstract][Full Text] [Related]
12. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
[TBL] [Abstract][Full Text] [Related]
13. Anethole and Its Role in Chronic Diseases.
Aprotosoaie AC; Costache II; Miron A
Adv Exp Med Biol; 2016; 929():247-267. PubMed ID: 27771928
[TBL] [Abstract][Full Text] [Related]
14. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
15. Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.
Vougogiannopoulou K; Ferandin Y; Bettayeb K; Myrianthopoulos V; Lozach O; Fan Y; Johnson CH; Magiatis P; Skaltsounis AL; Mikros E; Meijer L
J Med Chem; 2008 Oct; 51(20):6421-31. PubMed ID: 18816110
[TBL] [Abstract][Full Text] [Related]
16. Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).
Scobie MR; Houke HR; Rice CD
Chem Biol Interact; 2019 Oct; 312():108816. PubMed ID: 31505164
[TBL] [Abstract][Full Text] [Related]
17. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.
Moon MJ; Lee SK; Lee JW; Song WK; Kim SW; Kim JI; Cho C; Choi SJ; Kim YC
Bioorg Med Chem; 2006 Jan; 14(1):237-46. PubMed ID: 16182537
[TBL] [Abstract][Full Text] [Related]
19. [Application of traditional Chinese patent drugs in cancer treatment].
Li PW
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):400. PubMed ID: 21875476
[No Abstract] [Full Text] [Related]
20. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
